Phase 1b/2 "RAINIER" Frontline Acute Myeloid Leukemia (AML) Trial Initiated

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/27/2026

1. NVDA
2. OKTA
3. CRM
4. CRWD
5. VEEV
6. KKR
7. P
8. HPQ
9. NTNX
10. SNPS

Go back to Phase 1b/2 "RAINIER" Frontline Acute Myeloid Leukemia (AML) Trial Initiated
(NASDAQ: APVO) Delayed: 2.39 -0.02 (0.83%)
Previous Close $2.41    52 Week High $4.33 
Open $2.41    52 Week Low $1.80 
Day High $2.42    P/E N/A 
Day Low $2.36    EPS $0.00 
Volume 7,647